Ely H
Department of Dermatology, University of California, Davis.
Dermatol Clin. 1988 Oct;6(4):585-608.
The conditions treatable with PTX are limited only by our understanding of disease pathogenesis. Surely the reader will think of new applications. I would caution at this point that PTX is not the primary treatment for any cutaneous condition but may be a valuable therapeutic adjunct.
可用紫杉醇治疗的病症仅受限于我们对疾病发病机制的理解。读者肯定会想到新的应用。在这一点上我要提醒的是,紫杉醇并非任何皮肤病症的主要治疗方法,但可能是一种有价值的治疗辅助手段。